OpenAlex
PricingAboutJobs
Log inGet started
Work

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

HTML

Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
DOI: 10.2337/dc15-0781
Authors: Tomoya Mita, Naoto Katakami, Hidenori Yoshii, Tomio Onuma, Hideaki Kaneto, Takeshi Osonoi, Toshihiko Shiraiwa, Keisuke Kosugi, Yutaka Umayahara, Tsunehiko Yamamoto, Hiroki Yokoyama, Nobuichi Kuribayashi, Hideaki Jinnouchi, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada
Institutions: Juntendo University, The University of Osaka, Juntendo Tokyo Koto Geriatric Medical Center, Osaka Police Hospital, Osaka Prefectural Medical Center, Kansai Rosai Hospital, University of Tsukuba
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: alogliptin, DPP-4 inhibitors, carotid atherosclerosis, type 2 diabetes, intima-media thickness, atherosclerosis progression, glucose-lowering effect, hypoglycemia, glucagon-like peptide-1, carotid artery
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2182241779
FWCI: 11.66
Cites: 39
Cited by: 159
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security